| Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors LG Buchynska, IP Nesina, NP Yurchenko, OO Bilyk, VN Grinkevych, ... Experimental oncology, 2007 | 64 | 2007 |
| Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers L Buchynska, N Iurchenko, V Grinkevych, I Nesina, S Chekhun, ... Experimental Oncology, 2009 | 32 | 2009 |
| Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1 M Mints, M Mushtaq, N Iurchenko, L Kovalevska, MC Stip, D Budnikova, ... Oncotarget 7 (16), 22150, 2016 | 30 | 2016 |
| Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas LG Buchynska, OV Brieiev, NP Iurchenko Experimental Oncology 41 (2), 138-143, 2019 | 17 | 2019 |
| Markers of the epithelial-mesenchymal transition in cells of endometrial carcinoma IP Nesina, NP Iurchenko, LG Buchynska Experimental oncology, 2018 | 17 | 2018 |
| Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer NP Iurchenko, NM Glushchenko, LG Buchynska Experimental oncology, 262-266, 2014 | 15 | 2014 |
| FOXP3 gene promoter methylation in endometrial cancer cells LG Buchynska, NP Iurchenko, NP Verko, KA Nekrasov, VI Kashuba Experimental oncology, 246-249, 2015 | 13 | 2015 |
| Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium LG Buchynska, TV Borykun, NP Iurchenko, SV Nespryadko, IP Nesina Experimental Oncology 42 (4), 289-294, 2020 | 9 | 2020 |
| Assessment of DNA status and peculiarities of expression of cyclins D1 and transcription factor E2F1 in cells of epithelial endometrial tumors NP Iurchenko, NM Glushchenko, LG Buchynska Onkologiya 21, 230-7, 2019 | 8 | 2019 |
| Overexpression of the mitochondrial ribosomal protein S18-2 in the invasive breast carcinomas LG Buchynska, NP Iurchenko, EV Kashuba, OV Brieieva, ... Experimental Oncology 40 (4), 303-308, 2018 | 8 | 2018 |
| Phenotypic features of endometrial tumors in patients with family history of cancer LG Buchynska, NP Lurchenko, NM Glushchenko, IP Nesina Experimental Oncology, 2017 | 8 | 2017 |
| Molecular phenotype of high-grade endometrioid carcinoma of the endometrium LG Buchynska, NM Glushchenko, IP Nesina, OV Brieieva, NP Iurchenko Experimental oncology 42 (4), 300-305, 2020 | 7 | 2020 |
| Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12+-fibroblasts in endometrioid carcinoma of endometrium LG Buchynska, OM Movchan, NP Iurchenko Experimental Oncology 43 (2), 135-141, 2021 | 6 | 2021 |
| The study of chromosomal instability in patients with endometrial cancer IP Nesina, NP Iurchenko, SV Nespryad’ko, LG Buchynska Experimental oncology, 202-206, 2014 | 6 | 2014 |
| Peculiarities of c-Myс protein expression in endometrial carcinomas with signs of aggressive disease OV Brieieva, IP Nesina, NP Iurchenko, LG Buchynska Oncologiya 21, 304-9, 2019 | 5 | 2019 |
| Risk assessment of cancer of the female reproductive system NM Glushchenko, IP Nesina, NP Iurchenko, LA Proskurnya, ... Experimental oncology, 207-211, 2014 | 4 | 2014 |
| Features of recurrence of endometrioid type endometrial cancer of I stage OM Movchan, VS Svintsitskiy, NP Tsip, SV Nespryadko, OI Bublіieva, ... Experimental Oncology 43 (4), 365-369, 2021 | 2 | 2021 |
| Serum steroid hormone levels in endometrial cancer patients with different menstrual function and indicators of genomic instability INP Nesinа ІP, OV Brieieva Оncologiya 18, 210-15, 2016 | 2 | 2016 |
| Статус рецепторів стероїдних гормонів у карциномах ендометрія як важливий прогностичний показник у хворих постменопаузального періоду ЛГ Бучинська, НП Юрченко, ІП Несіна, НМ Глущенко, ЛА Проскурня Онкологія, 2016 | 2 | 2016 |
| Сlinico-genealogical and genetic-mathematical approach to the assessment of susceptibility to female’s organs reproductive system cancer NM Glushchenko, NP Iurchenko, IP Nesina, LG Buchynska Oncology 15 (2), 104-7, 2013 | 2 | 2013 |
